Closing Bell: Medexus Pharmaceuticals Inc down on Thursday (MDP)

Today during trading, Medexus Pharmaceuticals Inc opened at $2.28 and closed at $2.21. It traded at a low of $2.19 to a high of $2.34.

Shares decreased -3.07% from the previous day's close of $2.28.

During the day across North America, the TSX Composite closed -0.54% at 22726.76, the S&P 500 closed -1.39% at 5588.27, the Dow Jones Industrial Average closed 0.59% at 41198.08 and the Nasdaq Composite closed -2.77% at 17996.92.

Medexus Pharmaceuticals Inc traded under MDP on the Toronto Stock Exchange (TSX).

A total of 23,958 shares was traded during the last trading day, with total trades of 58. On average, Medexus Pharmaceuticals Inc has traded 19,340 shares over 5 days and 50,895 year-to-date.

Trading across the entire TSX saw 1,017 price advancers against 4,222 declines and 91 unchanged.

During the prior 52 weeks, MDP.TO has traded as high as $3.53 (August 24,2023) and low as $1.44 (December 04,2023). Moreover, the shares have boosted 5.24% in the last year, while in 2024, they have dipped -10.53%.

Following today's trading, Medexus Pharmaceuticals Inc has a market capitalization of $55.77 million on a float of 24,459 shares outstanding. Its annual EPS is $-0.01.

Medexus Pharmaceuticals Inc is a TSX Drug Specialty & Generic company headquartered in Toronto, CAN.

Medexus Pharmaceuticals Inc's average recommendation is "Moderate Buy" based on 4.00 analysts according to Zacks. Currently, there are 3 buy ratings and 1 hold ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..